Spectra7 Announces Completion of Debenture Amendments
December 13th, 2021 SAN JOSE, CA - (AccessWire) – (TSXV:SEV) (OTCQB:SPVNF) Spectra7 Microsystems Inc. (“Spectra7” or the “Company”), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, announces that the Company has entered into a second supplemental convertible debenture indenture (the “Supplemental Indenture”) on December 9, 2021 to bring into effect the previously announced amendments to the Company’s existing 7% unsecured convertible debentures (the “Debentures”). The Supplemental Indenture amends the conversion price of the principal amount of the Debentures from $5.00 per common share to $2.50 per common share during the period from January 9, 2022 to July 9, 2022 (the “Amendment”).
The Debentures are currently convertible at a price of $2.50 per common share until January 8, 2022. As a result of the Amendment, the conversion price will remain at the current price of $2.50 per common share until maturity. The interest rate and other features of the Debentures are not being amended.
ABOUT SPECTRA7 MICROSYSTEMS INC.
Spectra7 Microsystems Inc. is a high-performance analog semiconductor company delivering unprecedented bandwidth, speed and resolution to enable disruptive industrial design for leading electronics manufacturers in virtual reality, augmented reality, mixed reality, data centers and other connectivity markets. Spectra7 is based in San Jose, California with a design center in Cork, Ireland and technical support location in Dongguan, China.
Neither the TSX Venture Exchange nor its regulation services provided (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information, please contact:
Matt Kreps/Jim Fanucchi
Darrow Associates
214-597-8200
ir@spectra7.com
Spectra7 Microsystems Inc.
Bonnie Tomei
Chief Financial Officer
669-212-1089
ir@spectra7.com
Spectra7 Microsystems Inc.
John Mitchell
Public Relations
650-269-3043
pr@spectra7.com